MIAMI--(BUSINESS WIRE)--IVAX Diagnostics, Inc. (NYSE Amex:IVD) announced today that its audited consolidated financial statements for the fiscal year ended December 31, 2010, included in its Annual Report on Form 10-K which was filed with the Securities and Exchange Commission on March 30, 2011, contained a report from its independent registered public accounting firm that indicates there is a substantial doubt about IVAX Diagnostics’ ability to continue as a going concern.
